loadpatents
name:-0.18717980384827
name:-0.020184993743896
name:-0.0077319145202637
KOEPPEN; Hartmut Patent Filings

KOEPPEN; Hartmut

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOEPPEN; Hartmut.The latest application filed is for "biomarkers and methods of treating pd-1 and pd-l1 related conditions".

Company Profile
7.17.44
  • KOEPPEN; Hartmut - San Mateo CA
  • Koeppen; Hartmut - South San Francisco CA
  • Koeppen; Hartmut - Berkeley CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20220146517 - KOWANETZ; Marcin ;   et al.
2022-05-12
Biomarkers and methods of treating PD-1 and PD-L1 related conditions
Grant 11,299,544 - Chen , et al. April 12, 2
2022-04-12
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20210140967 - KOWANETZ; Marcin ;   et al.
2021-05-13
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20200333348 - KOWANETZ; Marcin ;   et al.
2020-10-22
Anti-pd-l1 Antibodies And Diagnostic Uses Thereof
App 20200270348 - KOWANETZ; Marcin ;   et al.
2020-08-27
Anti-PD-L1 antibodies and diagnostic uses thereof
Grant 10,689,445 - Kowanetz , et al.
2020-06-23
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20200041520 - KOWANETZ; Marcin ;   et al.
2020-02-06
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20190195882 - KOWANETZ; Marcin ;   et al.
2019-06-27
Cancer treatment with c-met antagonists and correlation of the latter with HGF expression
Grant 10,240,207 - Yu , et al.
2019-03-26
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20180313845 - KOWANETZ; Marcin ;   et al.
2018-11-01
Anti-pd-l1 Antibodies And Diagnostic Uses Thereof
App 20180022809 - KOWANETZ; Marcin ;   et al.
2018-01-25
Cancer Treatment With C-met Antagonists And Correlation Of The Latter With Hgf Expression
App 20170183740 - YU; Wei ;   et al.
2017-06-29
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20170052188 - KOWANETZ; Marcin ;   et al.
2017-02-23
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20160222118 - CHEN; Daniel Shin-Yu ;   et al.
2016-08-04
Anti-pd-l1 Antibodies And Diagnostic Uses Thereof
App 20160009805 - KOWANETZ; Marcin ;   et al.
2016-01-14
Combination Treatments Comprising C-met Antagonists And B-raf Antagonists
App 20150125452 - Wilson; Timothy R. ;   et al.
2015-05-07
Anti-neuropilin antibodies and methods of use
Grant 8,993,249 - Schmidt , et al. March 31, 2
2015-03-31
Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions
App 20150071910 - KOWANETZ; Marcin ;   et al.
2015-03-12
Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
Grant 8,728,480 - Cairns , et al. May 20, 2
2014-05-20
Methods Of Treating Tumors
App 20140038959 - Hoeflich; Klaus P. ;   et al.
2014-02-06
Anti-neuropilin Antibodies And Methods Of Use
App 20130115626 - SCHMIDT; MAIKE ;   et al.
2013-05-09
Combination Treatments Comprising C-met Antagonists And B-raf Antagonists
App 20130078252 - Wilson; Timothy R. ;   et al.
2013-03-28
Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
App 20130064761 - Cairns; Belinda ;   et al.
2013-03-14
Compositions and methods for the treatment of tumor of hematopoietic origin
Grant 8,388,973 - Chang , et al. March 5, 2
2013-03-05
Compositions and methods for the diagnosis and treatment of tumor
Grant 8,278,042 - Cairns , et al. October 2, 2
2012-10-02
Compositions And Methods For The Treatment Of Tumor Of Hematopoietic Origin
App 20110268657 - Chang; Wesley ;   et al.
2011-11-03
Compositions and methods for the treatment of tumor of hematopoietic origin
Grant 7,888,478 - Chang , et al. February 15, 2
2011-02-15
Compositions and methods for the treatment of tumor of hematopoietic origin
Grant 7,858,330 - Hongo , et al. December 28, 2
2010-12-28
Compositions and methods for the diagnosis and treatment of tumor
App 20100311050 - Cairns; Belinda ;   et al.
2010-12-09
Compositions And Methods For The Diagnosis And Treatment Of Tumor
App 20100303834 - CAIRNS; BELINDA ;   et al.
2010-12-02
Antibody compositions for the diagnosis and treatment of tumor
Grant 7,803,915 - Cairns , et al. September 28, 2
2010-09-28
Anti-TAT188 antibodies
Grant 7,749,504 - Cairns , et al. July 6, 2
2010-07-06
Cancer Prognostic Diagnostic And Treatment Methods
App 20090324595 - Jubb; Adrian M. ;   et al.
2009-12-31
Compositions and methods for the diagnosis and treatment of tumor
App 20090324592 - Caims; Belinda ;   et al.
2009-12-31
Compositions and methods for the diagnosis and treatment of tumor
App 20090324490 - Caims; Belinda ;   et al.
2009-12-31
Compositions And Methods For The Diagnosis And Treatment Of Tumor
App 20090297531 - Carins; Belinda ;   et al.
2009-12-03
Compositions and methods for the diagnosis and treatment of tumor
App 20090246129 - Caims; Belinda ;   et al.
2009-10-01
Compositions and Methods for the Diagnosis and Treatment of Tumor
App 20090136928 - Cairns; Belinda ;   et al.
2009-05-28
Compositions and methods for the diagnosis and treatment of tumor
App 20090081660 - Cairns; Belinda ;   et al.
2009-03-26
Anti-tumor antibody compositions and methods of use
Grant 7,435,416 - Devaux , et al. October 14, 2
2008-10-14
Compositions and methods for the diagnosis and treatment of tumor
App 20080227106 - Cairns; Belinda ;   et al.
2008-09-18
Compositions and methods for the diagnosis and treatment of tumor
Grant 7,390,882 - Cairns , et al. June 24, 2
2008-06-24
Compositions And Methods For The Diagnosis And Treatment Of Tumor
App 20080124331 - Cairns; Belinda ;   et al.
2008-05-29
Cancer Prognostic Diagnostic And Treatment Methods
App 20080008705 - Jubb; Adrian M. ;   et al.
2008-01-10
Achaete-Scute Like-2 Polypeptides and Encoding Nucleic Acids and Methods for the Diagnosis and Treatment of Tumor
App 20070117124 - Baldwin; Daryl ;   et al.
2007-05-24
Compositions and Methods for the Diagnosis and Treatment of Tumor
App 20070048326 - Cairns; Belinda ;   et al.
2007-03-01
Compositions and methods for the treatment of tumor of hematopoietic origin
App 20060251662 - Chang; Wesley ;   et al.
2006-11-09
Compositions and methods for the treatment of tumor of hematopoietic origin
App 20060216232 - Chang; Wesley ;   et al.
2006-09-28
Compositions and methods for the diagnosis and treatment of tumor
App 20060160997 - Cairns; Belinda ;   et al.
2006-07-20
Compositions and methods for the diagnosis and treatment of tumor
App 20060147373 - Cairns; Belinda ;   et al.
2006-07-06
Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
App 20050260634 - Baldwin, Daryl ;   et al.
2005-11-24
Compositions and methods for the treatment of tumor of hematopoietic origin
App 20050226869 - Chang, Wesley ;   et al.
2005-10-13
Compositions and methods for the diagnosis and treatment of tumor
App 20050106644 - Cairns, Belinda ;   et al.
2005-05-19
Compositions and methods for the diagnosis and treatment of tumor
App 20050107595 - Cairns, Belinda ;   et al.
2005-05-19
Anti-tumor antibody compositions and methods of use
App 20050036942 - Devaux, Brigitte ;   et al.
2005-02-17
Anti-tumor antibody compositions and methods of use
Grant 6,824,780 - Devaux , et al. November 30, 2
2004-11-30
Notch receptor agonists and uses
Grant 6,689,744 - Gao , et al. February 10, 2
2004-02-10
Notch receptor agonists and uses
App 20030082651 - Gao, Wei-Qiang ;   et al.
2003-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed